During a live event, Benjamin Garmezy, MD, discussed treatment options in renal cell carcinoma including IO/TKI combinations ...

New Delhi, 3 Jan 2025 (IANS) Immuno-oncology (IO) drugs or cancer therapeutics represent one of the most promising areas of medical innovation in the next five years, according to a report on Friday.

Photo provided=Lee Sol's SNS account Comedian Park Sung-kwang's wife Lee Sol confessed to fighting cancer. On the 2nd, Lee ...

Exelixis, Inc. EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib). The ...

EXEL stock gains on the back of encouraging performance of its lead drug Cabometyx and efforts to improve shareholder value. However, the recent rally might limit further gains for shareholders.

Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new ...

Spanios is pleased to announce strategic partnership with GlioGuard aimed at propelling discovery and validation of ...

Stimulants are the most common ADHD medications, but they don’t work for everyone. Nonstimulants have fewer side effects but take longer to work. If you have attention deficit hyperactivity ...